This information is for residents of Australia.
SPIKEVAX® (elasomeran) COVID‑19 Vaccine
SPIKEVAX (elasomeran) COVID-19 Vaccine is indicated for:
Active immunisation to prevent coronavirus disease 2019 (COVID-19) caused by SARS-CoV-2 in individuals 6 years of age and older.
SPIKEVAX (elasomeran) COVID-19 Vaccine has provisional approval for the indication below:
Active immunisation to prevent coronavirus disease 2019 (COVID-19) caused by SARS-CoV-2 in individuals 6 months of age to <6 years of age.
PRODUCT INFORMATION
CONSUMER MEDICINE INFORMATION
Report an adverse event or product complaint
You can report an adverse event to Moderna via the Adverse Event Intake Portal or by calling 1800 344 018
For any request for medical information or any other safety information:
Call: 1800 344 018 (9am-5pm AEST Mon-Fri)
Email: WeCare@modernatx.com